MILANA AGADZHANYAN: Open Payments
NPI 1669821534 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$710 in 26 payments from 10 companies in 2025. Trend: 2023 $816 · 2024 $736 · 2025 $710
Food & beverage: $710
| Company | Payments | Amount |
|---|---|---|
| Harrow Eye, LLC | 10 | $218 |
| Amgen Inc. | 1 | $125 |
| Bausch & Lomb Americas Inc. | 5 | $114 |
| Dompe US, Inc. | 2 | $50 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $49 |
| Regeneron Healthcare Solutions, Inc. | 1 | $38 |
| ABBVIE INC. | 2 | $35 |
| Apellis Pharmaceuticals, Inc. | 1 | $33 |
| Alcon Vision LLC | 1 | $28 |
| Thea Pharma Inc. | 1 | $19 |
Products named: VEVYE, TEPEZZA, XIIDRA, OXERVATE, Cequa, EYLEA HD, LUMIGAN, Syfovre.
Industry payments across NY — which companies pay providers there.
